HemaSphere (May 2023)

P54 ORAL ANTIVIRALS RITONAVIR-NIRMATRELVIR AND MOLNUPIRAVIR ARE HIGHLY EFFECTIVE IN PATIENTS WITH MULTIPLE MYELOMA AND COVID-19; A SINGLE-CENTER, PROSPECTIVE STUDY

  • V. Spiliopoulou,
  • I. Ntanasis-Stathopoulos,
  • P. Malandrakis,
  • M. Gavriatopoulou,
  • F. Theodorakakou,
  • D. Fotiou,
  • R. E. Syrigou,
  • M. Migkou,
  • M. Roussou,
  • E. Eleutherakis-Papaiakovou,
  • E. Kastritis,
  • M. A Dimopoulos,
  • E. Terpos

DOI
https://doi.org/10.1097/01.HS9.0000936344.05666.80
Journal volume & issue
Vol. 7, no. S2
pp. 40 – 41

Abstract

Read online

No abstracts available.